Clinical Trials on Relapsed or Refractory Acute Leukemia in Canada
Total 661 results
-
Syndax PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Undifferentiated Leukemia | Relapsed/Refractory Leukemias | Mixed Phenotype Acute LeukemiaUnited States, Canada
-
AmgenTerminatedRelapsed/Refractory Acute Myeloid Leukemia (AML)United States, Korea, Republic of, Australia, Japan, Germany, Canada
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
Seattle Children's HospitalChildren's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...CompletedAML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDSUnited States, Canada
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
University Health Network, TorontoAbbVie; CelgeneTerminatedAcute Myeloid Leukemia | Relapsed Cancer | Refractory Cancer | IDH2 Gene MutationCanada
-
Arog Pharmaceuticals, Inc.RecruitingRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States, Germany, Spain, Italy, France, Canada
-
University Health Network, TorontoActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Relapsed Cancer | Refractory CancerCanada
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States, Canada
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
Kite, A Gilead CompanyCompletedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Germany, Netherlands, Canada
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory B-precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B-Cell Non-Hodgkin LymphomaSpain, United States, Canada, Belgium, Poland, Czechia, Italy, France, Germany, Netherlands, Sweden
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
PETHEMA FoundationCompletedAcute Myeloblastic LeukaemiaSpain
-
National Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia in Remission | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia and other conditionsCanada
-
AmgenTerminatedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Italy, Belgium, Canada, Mexico, Germany, Korea, Republic of, United Kingdom, Taiwan, Australia, Spain, Austria, Israel, Czechia, Greece, Russian Federation, Poland, Turkey, Bulgaria, Ireland
-
Epizyme, Inc.Celgene CorporationCompletedAcute Myeloid Leukemia | Leukemia | Acute Lymphocytic Leukemia | Acute LeukemiasUnited States, Canada
-
University of AlbertaWithdrawnLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Acute | Leukemia, Monocytic, Acute | Leukemia, Megakaryoblastic, Acute | Leukemia, Erythroblastic, AcuteCanada
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) | Secondary Acute Myeloid Leukemia and other conditionsCanada
-
University Health Network, TorontoMerck Sharp & Dohme LLCCompletedAcute Myeloid LeukemiaCanada
-
Hamilton Health Sciences CorporationUnknownLeukemia, Myeloid, AcuteCanada
-
Maisonneuve-Rosemont HospitalUnknown
-
University Health Network, TorontoCompleted
-
University Health Network, TorontoNovartis PharmaceuticalsTerminated
-
Sarit AssoulineCompleted
-
University Health Network, TorontoCelgene CorporationCompleted
-
Synta Pharmaceuticals Corp.UnknownAcute Myeloid LeukemiaCanada
-
Novartis PharmaceuticalsNo longer availableFLT3-mutated Acute Myeloid LeukemiaCanada
-
University Health Network, TorontoOzmosis Research Inc.Active, not recruitingAcute Myeloid LeukemiaCanada
-
Jewish General HospitalThe Leukemia and Lymphoma SocietyCompleted
-
Ontario Clinical Oncology Group (OCOG)Hamilton Health Sciences Corporation; Juravinski Cancer Centre FoundationCompleted
-
Jewish General HospitalThe Leukemia and Lymphoma SocietyCompletedAcute Myelocytic LeukemiaCanada
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
University Health Network, TorontoOzmosis Research Inc.RecruitingAcute Myeloid LeukemiaCanada
-
Hoffmann-La RocheCompletedNeoplasms, Myelogenous Leukemia, AcuteUnited States, Canada
-
University Health Network, TorontoCompletedAcute Myeloid LeukemiaCanada
-
University of AlbertaAlberta Cancer Foundation; Canadian Cancer Trials GroupRecruitingRelapsed Non Hodgkin Lymphoma | Relapsed Pediatric ALL | Relapsed Adult ALLCanada
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Novartis PharmaceuticalsCompletedAcute LeukemiasHungary, Belgium, Germany, Austria, Netherlands, Australia, Canada, Spain, Norway, United Kingdom, United States
-
University Health Network, TorontoMemorial Sloan Kettering Cancer Center; University of California, Los Angeles; University of KansasCompletedAcute Myeloid LeukemiaUnited States, Canada
-
AstraZenecaTerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Astellas Pharma Global Development, Inc.TerminatedAcute Myeloid LeukemiaUnited States, Canada
-
Toronto Rehabilitation InstituteUniversity Health Network, Toronto; The Leukemia and Lymphoma SocietyCompletedQuality of Life | Acute Myeloid Leukemia | Fatigue | ExerciseCanada
-
AstraZenecaTerminatedAcute Myelogenous LeukemiaUnited States, Canada
-
Genentech, Inc.Completed
-
Centre de recherche du Centre hospitalier universitaire...WithdrawnAcute Myeloid LeukemiaCanada
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompletedAcute Myeloid LeukemiaCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genzyme, a Sanofi CompanyTerminatedAcute Myeloid Leukemia | Myeloproliferative Disorders | Myelofibrosis | Chronic Myelomonocytic Leukemia | Juvenile Myelomonocytic Leukemia | Acute Leukemia | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Acute Promyelocytic Leukemia | Chronic Myelogenous LeukemiaUnited States, Canada